首页> 美国卫生研究院文献>other >Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma

【2h】

Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma

机译：基于S-1方案与基于氟尿嘧啶静脉注射的方案在亚洲转移性结直肠癌患者中的疗效和安全性评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:We performed the present systematic review and meta-analysis to evaluate the efficacy and safety for S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma (mCRC).

机译：背景：我们进行了本系统的综述和荟萃分析，以评估基于S-1方案与基于氟尿嘧啶静脉注射的方案在亚洲转移性结直肠癌（mCRC）患者中的疗效和安全性。

著录项

期刊名称 other
作者
Jianxin Chen; Junhui Wang;
展开▼
作者单位

展开▼
年(卷),期 -1(98),23
年度 -1
页码 e15999
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
Asian colorectal carcinoma intravenous fluorouracil meta-analysis S-1;

机译：亚洲;结直肠癌;静脉内氟尿嘧啶;荟萃分析;S-1;

相似文献

外文文献
中文文献
专利

1. Meta-analysis comparing the safety and efficacy of metastatic colorectal cancer treatment regimens, capecitabine plus irinotecan (CAPIRI) and 5-fluorouracil/leucovorin plus irinotecan (FOLFIRI) [J] . Ding Hong-hua, Wu Wei-dong, Jiang Tao, Tumour biology : . 2015,第5期

机译：荟萃分析比较转移性结直肠癌治疗方案，卡培他滨加伊立替康（CAPIRI）和5-氟尿嘧啶/亚叶酸钙加伊立替康（FOLFIRI）的安全性和有效性
2. Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab [J] . Masahito Kotaka, Ruihua Xu, Kei Muro, Chinese journal of cancer . 2016,第1期

机译：亚洲XELIRI项目（AXEPT）的研究方案：一项针对转移性结直肠癌的二线化疗的跨国，非劣效，非劣效性III期临床试验，比较了有或没有贝伐单抗与有或没有贝伐单抗的FOLFIRI的疗效和安全性
3. Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab [J] . Masahito Kotaka, Ruihua Xu, Kei Muro, Cancer Communications . 2016,第1期

机译：亚洲XELIRI项目（AXEPT）的研究方案：一项针对转移性结直肠癌的二线化疗的跨国，非劣效，非劣效性III期临床试验，比较了有或没有贝伐单抗与有或没有贝伐单抗的FOLFIRI的疗效和安全性
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Evaluating response to treatment and predicting outcome in patients with metastatic colorectal carcinoma using statistical learning theory . [D] . Margolis, Daniel Eli. 2010

机译：运用统计学习理论评价转移性大肠癌患者的治疗反应和预测结局。
6. Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational randomized non-inferiority phase III trial of second-line chemotherapy for metastatic colorectal cancer comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab [O] . Masahito Kotaka, Ruihua Xu, Kei Muro, 2016

机译：亚洲XELIRI ProjecT（AXEPT）的研究方案：一项针对转移性结直肠癌的二线化疗的跨国非劣效非劣效性三期临床试验比较了XELIRI联合或不联合贝伐单抗与FOLFIRI联合或不联合贝伐单抗的疗效和安全性
7. Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma [O] . Jianxin Chen, Junhui Wang 2019

机译：基于S-1的方案的疗效和安全评估与脑转移结直肠癌患者静脉内氟尿嘧啶癌

Efficacy and safety assessment of S-1-based regimens comparing to intravenous fluorouracil-based ones in Asian patients with metastatic colorectal carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅